2Wang P,Branch D-R,Bali M,et al.The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells[J].Biochem J,2003,375(1):199-205.
3Gronbaek K,Ralfkiaer,Kalla J,et al.Infrequent somatic Fas mutations but no evidence of Bc11O mutations or t(11:18) in primary cutaneous MALT-type lymphoma[J].J Pathol,2003,201(1):134-140.
4Antonella Antignani,Richard J.A Chimeric Protein Induces Tumor Cell Apoptosis by Delivering the Human Bcl-2 Family BH3-Only Protein[J].Youle Biochemistry,2005,44(3):4074-4082.
5Reynolds PA,Smolen GA,Palmex RE,et al.Identification of a DNA-binding site and transcriptional target for the EWS-WT1 (+KTS) oncoprotein[J].Genes-Dev,2003,17(17):2094-2107.
6Xia Wang,Min Hou.A hybrid protein of the amino-terminal fragment of urokinaseand mutant plasminogen activator inhibitor-2 efficiently inhibits tumor cell invasion and metastasis[J].J Cancer Res Clin Oncol,2005,131(4):129-136.
7Ariane Dienst,Andrea Grunow,Maike Unruh,et al.Specifi c Occlusion of Murine and Human Tumor Vasculature by VCAM-1 Targeted Recombinant Fusion Proteins[J].Journal of the National Cancer Institute,2005,97(10):733-747.
8Tsuneaki Asai,Letitia A Wims,Sherie L Morrison,et al.An interaction between S * tag and S * protein derived from human ribonuclease 1 allows site-specific conjugation of an enzyme to an antibody for targeted drug delivery[J].Journal of Immunological Methods,2005,299(1-2):63-76.
9Asakura K,Uchida H,Mayachi H,et al.TEL/AMI1 overcomes drug residrance through transcriptional repression of muhidrug resistance-1 gene expression[J].Mol-Cancer-Res,2004,2(6):339-347.
10Sui Shen,Andres Forero,Albert Lobuglio,et al.Patient-Specific Dosimetry of Pretargeted Radioimmunotherapy Using CC49 Fusion protein in patient with gastrointestinal malignanciesCC49[J].The Journal of Nuclear Medicine,2005,46(4):642-651.
3Poplonska K, Wojtczak A, Kwiatkowska M ,et al. Cytochemical and immunocytochemical studies of the localization of histones and protamine-type proteins in spermatids of Chara vulgaris and Chara tomentosa[ J]. Folia Histochem Cytobiol,2007,45(4) :367-374.
4Ortner A, Wernig K, Kaisler R, et al. VPAC receptor mediated tumor cell targeting by protamine based nanoparticles [ J ]. J Drug Target,2010,18 (6) :457-467.
5Awe S, Renkawitz-Pohl R. Histone H4 acetylation is essential to proceed from a histotae-to a protam/ne-based chmmatin structure in spermatid nuclei of Drosophila melanogaster [ J ]. Syst Biol Reprod Med,2010,56( 1 ) :44-61.
6Wen WH, Liu jY, Qin wJ, et al. Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery[ J]. Hepatology,2007,46( 1 ) :84-94.
7李立家,肖庚富.基因工程[M].北京:北京科学技术出版社,2004:53-61.
8Aires da SilVa F, Costa M J, Corte-Real S, et al. Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti- CCR5 single-chain antibodies [ J ]. Hum Gene Ther,2005,16 ( 2 ) : 223 -234.
9Suzuki M,Takayanagi A, Shimizu N. Targeted gene delivery using humanized single-chain antibody with negatively charged oligo pep- tide tail[ J ]. Cancer Sci ,2004,95 (5) :424-429.
10Zhang T,Wang CY, Zhang W, et al. Generation and characteriza- tion of a fusion protein of single-chain fragment variable antibody against hemagglutinin antigen of avian influenza virus and trun- cated pmtamine [ J]. Vaccine ,2010,28 (23) :3949-3955.
